English
Home > Products > 22888-70-6

China 22888-70-6 Factory

As for aggressive rates, we believe that you will be searching far and wide for anything that can beat us. We can easily state with absolute certainty that for such good quality at such charges we are the lowest around for 22888-70-6,CAS NO 22888-70-6,Silibinin API,Silibinin, We could customize the goods according to your needs and we will pack it for you personally when you get.
22888-70-6, Our company's main merchandise are widely used all over the world; 80% of our products exported to the United States, Japan, Europe and other markets. All stuff sincerely welcome guests come to visit our factory.

Related Products

Hot Products

  • Lenalidomide

    Lenalidomide

    Product Name:Lenalidomide
    Molecular Formula:C13H13N3O3
    Molecular Weight;259.26
    CAS Registry Number;191732-72-6
  • Tetrahydropalmatine

    Tetrahydropalmatine

    Product Name:Tetrahydropalmatine
    Molecular Formula:C21H25NO4
    Molecular Weight:355.43
    CAS Registry Number:2934-97-6
  • 3-CHLORO-2-FLUORONITROBENZENE

    3-CHLORO-2-FLUORONITROBENZENE

    Product Name:3-CHLORO-2-FLUORONITROBENZENE
    Molecular Formula:C6H3ClFNO2
    Molecular Weight:175.54
    CAS Registry Number:2106-49-2
  • Ampicillin sodium

    Ampicillin sodium

    Product Name:Ampicillin sodium
    Molecular Formula:C16H20N3NaO4S
    Molecular Weight;373.4
    CAS Registry Number;69-52-3
  • 3,5-Difluorobenzyl alcohol

    3,5-Difluorobenzyl alcohol

    Product Name:3,5-Difluorobenzyl alcohol
    Molecular Formula:C7H6F2O
    Molecular Weight:144.12
    CAS Registry Number:79538-20-8
  • 4-Amino-3-chlorophenol

    4-Amino-3-chlorophenol

    Product Name:4-Amino-3-chlorophenol
    Molecular Formula:C6H6ClNO
    Molecular Weight:143.57
    CAS Registry Number:17609-80-2
  • Related Blog
  • Reviews

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • What is an Active Pharmaceutical Ingredient (API in Pharma)?

    Sandoo Pharmaceutical is a professional active pharmaceutical intermediate manufacturer, producing high quality APIs. Sandoo Pharmaceutical provides a wide range of active pharmaceutical intermediates.

  • How much do you know about minocycline hydrochloride?

    Minocycline hydrochloride is commonly used as its hydrochloride, which is yellow crystalline powder, odorless, bitter in taste, and can cause deterioration when exposed to light. Soluble in water, slightly soluble in ethanol, easily soluble in alkali metal hydroxide or carbonate solution.

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Related Search

CAS NO 22888-70-6

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept